Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
about
Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling.Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populations.Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.
P2860
Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Development of a Novel Materna ...... placental permeability drugs.
@en
Development of a Novel Materna ...... placental permeability drugs.
@nl
type
label
Development of a Novel Materna ...... placental permeability drugs.
@en
Development of a Novel Materna ...... placental permeability drugs.
@nl
prefLabel
Development of a Novel Materna ...... placental permeability drugs.
@en
Development of a Novel Materna ...... placental permeability drugs.
@nl
P2860
P356
P1476
Development of a Novel Materna ...... placental permeability drugs.
@en
P2093
Jashvant D Unadkat
Zufei Zhang
P2860
P304
P356
10.1124/DMD.116.073957
P577
2017-01-03T00:00:00Z